The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes
Open accessAbstract
Objective. We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes. Methods. This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort study. The predictor was based on two consecutive visits of hs-CRP levels in 2006 and 2008. A total of 3924 patients with hs-CRP≥3 mg/L in 2006 were divided into two groups according to whether the levels of hs-CRP were reduced in 2008: Group 1: no reduction: hs-CRP≥3 mg/L in 2008; Group 2: reduction: hs-CRP<3 mg/L in 2008. Kidney outcomes include kidney function decline and development and progression of proteinuria and were followed up until the end of 2015. Results. There were 3905, 2049, and 493 patients included into our analysis for the outcomes of kidney function decline and the development and progression of proteinuria, respectively. A total of 398, 297, and 47 events occurred after 5 years of follow-up, respectively. Cox regression revealed that patients with reduction in hs-CRP have lower risk of kidney function decline (HR 0.71, 95% CI 0.57-0.89, and P=0.002) and development of proteinuria (0.77, 0.61-0.99, and P=0.038) after controlling for potential confounders as compared to those with no reduction in hs-CRP levels. Conclusions. Reduction in serum hs-CRP levels favors kidney outcomes in patients with impaired fasting glucose or diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reductions in hsCRP have been linked to improved kidney outcomes.
“reductions in hsCRP have been linked to improved kidney outcomes [43].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Chronic Kidney Disease in China
Zhang, L., Long, J., Jiang, W., Shi, Y., He, X., Zhou, Z., Li, Y., Yeung, R. O., Wang, J., Matsushita, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1602469 · Cited by 765
Self-citation
Flagged first, then by citations
Research works printed but not linked: 28
- 10.2215/CJN.11491116 · DOI · Paper page
- 10.2215/CJN.07891109 · DOI · Paper page
- 10.1016/S0140-6736(12)60033-6 · DOI
- 10.1016/j.atherosclerosis.2017.02.003 · DOI
- 10.1007/s00125-010-1742-8 · DOI
- 10.5551/jat.33530 · DOI
- 10.1159/000488537 · DOI
- 10.1046/j.1523-1755.2002.00677.x · DOI
- 10.2337/dc08-0277 · DOI
- 10.1161/CIRCOUTCOMES.111.963694 · DOI
- 10.2337/diacare.26.11.3160 · DOI · Paper page
- 10.1253/circj.70.384 · DOI
- 10.7326/0003-4819-150-9-200905050-00006 · DOI · Paper page
- 10.1258/acb.2009.009007 · DOI
- 10.1161/JAHA.117.005610 · DOI
- 10.1001/jama.2014.6634 · DOI · Paper page
- 10.11909/j.issn.1671-5411.2018.01.011 · DOI
- 10.1016/j.amjcard.2005.06.074 · DOI
- 10.1016/j.ahj.2005.06.032 · DOI
- 10.5551/jat.39354 · DOI
- 10.1373/clinchem.2018.298489 · DOI
- 10.2337/dc14-1357 · DOI
- 10.1093/clinchem/43.1.52 · DOI
- 10.1016/j.clnu.2018.09.007 · DOI
- 10.2165/00007256-200636050-00006 · DOI
- 10.3390/nu6062206 · DOI
- 10.1161/CIRCRESAHA.115.306656 · DOI · Paper page
- 10.1096/fj.201801865RR · DOI
Cited by
Sorted by citations
Mosenzon, O., Capehorn, M. S., De Remigis, A., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01585-7 · Cited by 91
Metadata
- Authors
- Liu, L., Gao, B., Wang, J., Yang, C., Wu, S., Wu, Y., Chen, S., Li, Q., Zhang, H., Wang, G., Chen, M., Zhao, M.-H., & Zhang, L.
- Affiliations
- Peking University First Hospital (CN)
- Kailuan General Hospital (CN)
- Peking University (CN)
- Corresponding author
- Zhang, Luxia
- ORCID
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2020-06-10
- Volume
- 2020
- Pages
- 1-7
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC7303740
- OpenAlex
- W3034925568
- Cited by
- 11
- References
- 1
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Peking University (PKU2017LCX05, BMU2018MX020, BMU2019JI005, BMU2018JI012, BMU20160466, 2016YFC1305400, Z191100001119008, 81301296, 81771938, 91846101)
- University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research (PKU2017LCX05, BMU2018MX020, BMU2019JI005, BMU2018JI012, BMU20160466, 2016YFC1305400, Z191100001119008, 81301296, 81771938, 91846101)
- Ministry of Science and Technology of the People's Republic of China (PKU2017LCX05, BMU2018MX020, BMU2019JI005, BMU2018JI012, BMU20160466, 2016YFC1305400, Z191100001119008, 81301296, 81771938, 91846101)
- Beijing Nova Program Interdisciplinary Cooperation Project (PKU2017LCX05, BMU2018MX020, BMU2019JI005, BMU2018JI012, BMU20160466, 2016YFC1305400, Z191100001119008, 81301296, 81771938, 91846101)
- National Natural Science Foundation of China (PKU2017LCX05, BMU2018MX020, BMU2019JI005, BMU2018JI012, BMU20160466, 2016YFC1305400, Z191100001119008, 81301296, 81771938, 91846101)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- high-sensitivity C-reactive protein, renal function decline, proteinuria, impaired fasting glucose, diabetes mellitus, diabetic nephropathy, inflammation, Kailuan cohort
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, C-Reactive Protein, Diabetes Mellitus, Diabetic Nephropathies, Female, Glomerular Filtration Rate, Humans, Hypoglycemic Agents, Male, Middle Aged, Prognosis, Proteinuria, Glucose Intolerance, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
